All Facilities , From 2026-02-16 - 2026-02-27
AMR INDICATOR 3 :: Drug Resistance
n = 162 Number of Isolates
All Specimens All Organisms
n = 162 Number of Isolates
All Specimens All Organisms
| Anntibiotic | Total Tested | Number Susceptibility | % Susceptibility |
|---|---|---|---|
| Linezolid | 15 | 13 | 86.7 |
| Meropenem | 80 | 69 | 86.3 |
| Imipenem | 48 | 41 | 85.4 |
| Vancomycin | 36 | 30 | 83.3 |
| Ampicillin | 62 | 5 | 8.1 |
| Amikacin | 55 | 42 | 76.4 |
| Chloramphenicol | 41 | 30 | 73.2 |
| Nitrofurantoin | 61 | 43 | 70.5 |
| Erythromycin | 40 | 3 | 7.5 |
| Piperacillin | 9 | 6 | 66.7 |
| Piperacillin/Tazobactam | 83 | 54 | 65.1 |
| Rifampin | 22 | 14 | 63.6 |
| Clindamycin | 33 | 20 | 60.6 |
| Gentamicin | 107 | 61 | 57.0 |
| Cefotaxim | 4 | 2 | 50.0 |
| Flucytosine | 2 | 1 | 50.0 |
| Fluconazole | 2 | 1 | 50.0 |
| Amoxicillin | 4 | 2 | 50.0 |
| Cefepime | 49 | 23 | 46.9 |
| Nalidixic acid | 15 | 7 | 46.7 |
| Amoxicillin/ Clavulanic acid | 47 | 20 | 42.6 |
| Cefoxitin | 24 | 10 | 41.7 |
| Trimethoprim | 13 | 5 | 38.5 |
| Aztreonam | 21 | 8 | 38.1 |
| Doxycycline | 16 | 6 | 37.5 |
| Tetracycline | 46 | 17 | 37.0 |
| Ciprofloxacin | 126 | 44 | 34.9 |
| Ceftazidime | 89 | 31 | 34.8 |
| Trimethoprim/Sulfamethoxazole | 90 | 26 | 28.9 |
| Ampicillin/ Sulbactam | 18 | 5 | 27.8 |
| azithromycin | 8 | 2 | 25.0 |
| Penicillin G | 18 | 4 | 22.2 |
| Levofloxacin | 9 | 2 | 22.2 |
| Ceftriaxone | 94 | 18 | 19.1 |
| Cefuroxime | 42 | 8 | 19.0 |
| Cefotaxime | 55 | 10 | 18.2 |
| Moxifloxacin | 3 | 3 | 100.0 |
| Tobramycin | 1 | 1 | 100.0 |
| Oxacillin | 3 | 3 | 100.0 |
| Variconazole | 1 | 1 | 100.0 |
| Caspofungin | 2 | 2 | 100.0 |
| Voriconazole | 2 | 2 | 100.0 |
| Micafungin | 1 | 1 | 100.0 |
| Kanamycin | 1 | 1 | 100.0 |